Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
77.26 USD | -0.25% | +5.59% | +0.53% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.53% | 12.18B | |
+20.57% | 46.4B | |
-0.91% | 41.75B | |
+48.71% | 41.37B | |
-3.52% | 29.71B | |
+10.41% | 26.01B | |
-19.66% | 19.52B | |
+30.24% | 12.43B | |
+0.15% | 12.13B | |
+21.15% | 11.81B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio-Techne's Simple Western Platform Picked by Cizzle for Detection of Cancer Biomarker